Canada · Delayed Price · Currency is CAD Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of CAD 238.04 billion. The enterprise value is 311.05 billion.
| Market Cap | 238.04B |
| Enterprise Value | 311.05B |
Important Dates
The next confirmed earnings date is Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Nov 6, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.34% |
| Shares Change (QoQ) | -0.56% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 68.07% |
| Float | 5.69B |
Valuation Ratios
The trailing PE ratio is 49.68 and the forward PE ratio is 10.42.
| PE Ratio | 49.68 |
| Forward PE | 10.42 |
| PS Ratio | 2.63 |
| PB Ratio | 1.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.27 |
| P/OCF Ratio | 12.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.43, with an EV/FCF ratio of 19.96.
| EV / Earnings | 50.58 |
| EV / Sales | 3.48 |
| EV / EBITDA | 8.43 |
| EV / EBIT | 11.77 |
| EV / FCF | 19.96 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.74.
| Current Ratio | 1.27 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 2.41 |
| Debt / FCF | 5.78 |
| Interest Coverage | 6.98 |
Financial Efficiency
Return on equity (ROE) is 5.01% and return on invested capital (ROIC) is 13.49%.
| Return on Equity (ROE) | 5.01% |
| Return on Assets (ROA) | 5.78% |
| Return on Invested Capital (ROIC) | 13.49% |
| Return on Capital Employed (ROCE) | 11.18% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | 81,990 |
| Employee Count | 75,000 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.49 |
Taxes
| Income Tax | -232.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.39% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +17.39% |
| 50-Day Moving Average | 12.60 |
| 200-Day Moving Average | 11.97 |
| Relative Strength Index (RSI) | 61.39 |
| Average Volume (20 Days) | 123,566 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.35 |
Income Statement
In the last 12 months, Pfizer had revenue of CAD 90.37 billion and earned 6.15 billion in profits. Earnings per share was 0.27.
| Revenue | 90.37B |
| Gross Profit | 67.52B |
| Operating Income | 26.74B |
| Pretax Income | 5.97B |
| Net Income | 6.15B |
| EBITDA | 36.01B |
| EBIT | 26.74B |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has 16.61 billion in cash and 90.07 billion in debt, with a net cash position of -73.46 billion.
| Cash & Cash Equivalents | 16.61B |
| Total Debt | 90.07B |
| Net Cash | -73.46B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 121.30B |
| Book Value Per Share | 21.21 |
| Working Capital | 12.36B |
Cash Flow
In the last 12 months, operating cash flow was 19.01 billion and capital expenditures -3.43 billion, giving a free cash flow of 15.59 billion.
| Operating Cash Flow | 19.01B |
| Capital Expenditures | -3.43B |
| Depreciation & Amortization | 9.17B |
| Net Borrowing | 2.49B |
| Free Cash Flow | 15.59B |
| FCF Per Share | n/a |
Margins
Gross margin is 74.72%, with operating and profit margins of 29.58% and 6.80%.
| Gross Margin | 74.72% |
| Operating Margin | 29.58% |
| Pretax Margin | 6.61% |
| Profit Margin | 6.80% |
| EBITDA Margin | 39.85% |
| EBIT Margin | 29.58% |
| FCF Margin | 17.45% |
Dividends & Yields
This stock pays an annual dividend of 0.77, which amounts to a dividend yield of 5.81%.
| Dividend Per Share | 0.77 |
| Dividend Yield | 5.81% |
| Dividend Growth (YoY) | -1.48% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 225.77% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.34% |
| Shareholder Yield | 5.47% |
| Earnings Yield | 2.01% |
| FCF Yield | 6.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pfizer has an Altman Z-Score of 2.22 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.22 |
| Piotroski F-Score | 7 |